Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | PRKCA | P17252 | 5/20 | 0.42 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.42 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.42 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL10950542 | 0.98 | TSHR (0.50) | TSHRHPGDPRKCAPRKCEPRKCQ | |
| SCHEMBL14828465 | 0.92 | TSHR (0.44) | TSHRHPGDPRKCAPRKCEPRKCQ | |
| SCHEMBL14824448 | 0.86 | TSHR (0.59) | TSHRHPGDPLA2G2CATMTHRB | |
| Hexane SCHEMBL9703643 | 0.84 | MAPT (0.55) | TSHRHPGDPRKCAPRKCEPRKCQ | |
| SCHEMBL6423789 | 0.82 | TSHR (0.53) | TSHRHPGDUSP2PLA2G2CATM | |
| SCHEMBL12131534 | 0.82 | TSHR (0.33) | TSHRHPGDPRKCAPRKCEPRKCQ | |
| SCHEMBL11060479 | 0.81 | TSHR (0.50) | TSHRHPGDPRKCAPRKCEPRKCQ | |
| SCHEMBL2359280 | 0.81 | TSHR (0.55) | TSHRHPGDPLA2G2C | |
| SCHEMBL410384 | 0.81 | TSHR (0.36) | TSHRHPGDPRKCAPRKCEPRKCQ | |
| SCHEMBL409945 | 0.81 | TSHR (0.36) | TSHRHPGDPRKCAPRKCEPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130085203-A1 | (METH)ACRYLIC-MODIFIED ORGANOPOLYSILOXANE, RADIATION-CURABLE SILICONE COMPOSITION, SILICONE RELEASE LINER, AND MAKING METHODS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-04-04 | — | — | US | disclosed |
| US-20130085203-A1 | (METH)ACRYLIC-MODIFIED ORGANOPOLYSILOXANE, RADIATION-CURABLE SILICONE COMPOSITION, SILICONE RELEASE LINER, AND MAKING METHODS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-04-04 | — | — | US | disclosed |
| EP-2574638-A1 | (Meth)acrylic-Modified Organopolysiloxane, Radiation-Curable Silicone Composition, Silicone Release Liner, and Making Methods | Shin-Etsu Chemical Co., Ltd. (JP) | 2013-04-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130085203-A1 | (METH)ACRYLIC-MODIFIED ORGANOPOLYSILOXANE, RADIATION-CURABLE SILICONE COMPOSITION, SILICONE RELEASE LINER, AND MAKING METHODS | MMAB, IDUA, MSR1 | TSHR 101/4885HPGD 1409/4885PRKCA 4559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.